NEW YORK, Feb 5 (Reuters) - Drug research firm PPD Inc on Wednesday priced its initial public offering (IPO) at $27 per share, according to a person familiar with the matter, at the high end of its target range.
The IPO valued North Carolina-based PPD at $9.16 billion. The company had aimed to sell 60 million shares at a target price range of $24-$27 per share.
Representatives for PPD did not immediately respond to a request for comment. (Reporting by Joshua Franklin in New York Editing by Chris Reese)